Literature DB >> 9882558

Cellular mechanisms of diabetic vascular hypertrophy.

D Vranes1, M E Cooper, R J Dilley.   

Abstract

Mesenteric vascular hypertrophy occurs in experimental diabetes. The present study examines whether this medial hypertrophy originates via cellular hyperplasia or hypertrophy of smooth muscle cells or an increase in collagen content. Male Sprague-Dawley diabetic (streptozotocin, 50 mg/kg, i.v.) rats were compared with control rats after 3 weeks in order to study mesenteric and aortic smooth muscle cell size and degree of cellular polyploidy. Collagen content in the mesenteric vessels was examined via staining with Sirius red. Further groups of control and diabetic animals were studied after 7 and 14 days of diabetes to assess proliferation in the various layers of the vessel wall using incorporation of [3H]thymidine (0.5 mCi/kg, i.p.). Smooth muscle cell size was measured by a Coulter counter and polyploidy assessed using flow cytometry measurement of cellular DNA content. Diabetic smooth muscle cell size was reduced in both the aorta and the mesenteric vessels and polyploidy was increased in these cells. The collagen content of diabetic mesenteric media was proportionally increased. At day 7, diabetic mesenteric endothelial and adventitial layers showed increased [3H]thymidine labeling of cells and this was not observed in the media of these vessels. These findings indicate that increased endothelial and adventitial cell proliferation are early events in diabetes associated vascular hypertrophy. Furthermore, an increase in extracellular matrix within the media is an important feature of diabetes associated vascular hypertrophy. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9882558     DOI: 10.1006/mvre.1998.2107

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  11 in total

1.  Provinol prevents CsA-induced nephrotoxicity by reducing reactive oxygen species, iNOS, and NF-kB expression.

Authors:  Barbara Buffoli; Olga Pechánová; Stanislava Kojsová; Ramaroson Andriantsitohaina; Lorena Giugno; Rossella Bianchi; Rita Rezzani
Journal:  J Histochem Cytochem       Date:  2005-06-13       Impact factor: 2.479

2.  Glycemic control prevents microvascular remodeling and increased tone in type 2 diabetes: link to endothelin-1.

Authors:  Kamakshi Sachidanandam; Jim R Hutchinson; Mostafa M Elgebaly; Erin M Mezzetti; Anne M Dorrance; Kouros Motamed; Adviye Ergul
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-01-28       Impact factor: 3.619

Review 3.  Non-proliferative and Proliferative Lesions of the Cardiovascular System of the Rat and Mouse.

Authors:  Brian R Berridge; Vasanthi Mowat; Hirofumi Nagai; Abraham Nyska; Yoshimasa Okazaki; Peter J Clements; Matthias Rinke; Paul W Snyder; Michael C Boyle; Monique Y Wells
Journal:  J Toxicol Pathol       Date:  2016-07-29       Impact factor: 1.628

4.  Intracellular Ca2+ regulating proteins in vascular smooth muscle cells are altered with type 1 diabetes due to the direct effects of hyperglycemia.

Authors:  Yvonne M Searls; Rajprasad Loganathan; Irina V Smirnova; Lisa Stehno-Bittel
Journal:  Cardiovasc Diabetol       Date:  2010-02-01       Impact factor: 9.951

5.  Decrease in serum matrix metalloproteinase-9 and matrix metalloproteinase-3 levels in Zucker fa/fa obese rats after treatment with swertiamarin.

Authors:  Hb Vaidya; S Giri; M Jain; Rk Goyal
Journal:  Exp Clin Cardiol       Date:  2012

6.  Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome.

Authors:  Giuseppe Derosa; Angela D'Angelo; Filippo Scalise; Maria A Avanzini; Carmine Tinelli; Emmanouil Peros; Elena Fogari; Arrigo F G Cicero
Journal:  Heart Vessels       Date:  2007-11-26       Impact factor: 2.037

7.  Type-2 diabetes-induced changes in vascular extracellular matrix gene expression: relation to vessel size.

Authors:  WeiWei Song; Adviye Ergul
Journal:  Cardiovasc Diabetol       Date:  2006-02-17       Impact factor: 9.951

8.  Ultrastructure of Placenta of Gravidas with Gestational Diabetes Mellitus.

Authors:  Qian Meng; Li Shao; Xiucui Luo; Yingping Mu; Wen Xu; Chao Gao; Li Gao; Jiayin Liu; Yugui Cui
Journal:  Obstet Gynecol Int       Date:  2015-08-24

9.  Long-term outcomes of infrainguinal bypass surgery for patients with diabetes mellitus and tissue loss.

Authors:  Heekyung Jung; Jayun Cho; Hyung-Kee Kim; Jihye Kim; Seung Huh
Journal:  Ann Surg Treat Res       Date:  2014-12-26       Impact factor: 1.859

Review 10.  Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers.

Authors:  Camelia R Ban; Stephen M Twigg
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.